MedTrace Logo

Low Dose Irradiation for Small Bowel Transplant

NCT00382486 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2007-12-17

No results posted yet for this study

Summary

The specific aims of this study is to improve short and long-term patient and graft survival, to reduce the incidence and severity of allograft rejection, to reduce the incidence of infection and to reduce and/or eventually eliminate the need for long-term immunosuppression.

Conditions

  • Irreversible Intestinal Failure
  • Allograft Rejection

Interventions

PROCEDURE

Reduce the risk of allograft rejection

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Kareem M Abu-Elmagd, MD · University of Pittsburgh

Eligibility

Min Age
17 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-07-31
Completion
2003-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00382486 on ClinicalTrials.gov